U.S. Markets open in 8 hrs, 44 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,226.94 | 203.52 | 2.03% |
| NASDAQ | 2,154.06 | 41.62 | 1.97% |
| S&P 500 | 1,093.08 | 23.78 | 2.22% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 1.81 09:49 AM EST | |
|---|---|---|
| Day High | 1.87 09:30 AM EST |
|
| Range | 0.06 |
| Volume | 363,655 | |
|---|---|---|
| 30-Day Avg Vol | 1.68 M |
|
| Difference | -78.37% |
| Market Cap | 145.93 M | |
|---|---|---|
| Mkt Cap Chg | 2.35 M |
| Shares Out | 78.46 M | |
|---|---|---|
| % Shrs Traded | 0.46% | |
| 1yr EPS Est | -0.25 |
| 52-Wk Low | 0.23 | |
|---|---|---|
| 52-Wk High | 4.09 |
|
| Range | 3.86 |
| Prev Close | 1.83 11/6/09 | |
|---|---|---|
| Today's Open | 1.87 | |
| Change | 2.19% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 2.35 M |
| Revenue (LFY) | 3.34 M | |
|---|---|---|
| Earnings (LFY) | -17.50 M | |
| Earnings (MRQ) | -4.96 M | |
| Next Earn Est | -0.06 | |
| Next Earnings | 12/14/2009 |
|
| EPS (TTM) | -0.26 | |
| 1yr EPS Growth | -13.64% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -7.00 | |
| PEG Ratio | — | |
| Return on Equity | -146.71 | |
| Beta | 2.53 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Baseball players and AVANIR Pharmaceuticals know: A sacrifice is sometimes the only way to get ahead. The drug development firm in 2007 opted to sacrifice its marketed schizophrenia drug, FazaClo, in order ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.06 12/14/09 | — — |
—
—
|
| Last Quarter | — 6/30/09 | -0.06 6/30/09 |
—
—
|
| 2 Quarters Ago | — 3/31/09 | -0.06 3/31/09 |
—
—
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 590,925.00 | 3.34 M |
| Gross Profit | 746,532.00 | 2.13 M |
| Operating Income | -4.97 M | -22.58 M |
| Net Income | -4.96 M | -17.50 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts